Randomized trial of xed dose capecitabine compared to standard dose capecitabine in metastatic breast cancer: The X-7/7 trial
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers
Key Abstracts/Publications in Triple Negative Breast Cancer
Chairpersons :
Dr. Manisha Singh, Dr. Geetha Narayanan
Speaker :
Dr. Deenadayalan T.